glp-1 news today nov 2025 UCI MIND | ๐ Novo Nordisk announced disappointing results for their two clinical trials, EVOKE and EVOKE+, of their agonist semaglutide GLP-1 Market Trends and Global
Pay in 4 interest-free payments of $5.99 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Oct 7 - Oct 12



























